tirzepatide versus semaglutide once weekly vs. Semaglutide: Key Differences & Benefits Evaluating Dose Titration in Semaglutide
Description
While the total drug exposure remained comparable across all three sites, the thigh produced fewer acute gastrointestinal side effects in the study participants

For their weight loss program, the company provides patients with access to FDA-approved weight loss medications, a dedicated insurance concierge, ongoing provider support, and health coaching
Nat Commun

Gastrointestinal effects are the most frequently reported side effects and include: Nausea (1224% of patients): Often most pronounced during treatment initiation and dose escalation, typically improving over time Diarrhea (1323% of patients): May be transient or persistent, requiring dietary modifications Vomiting (611% of patients): Can lead to dehydration if severe or prolonged Constipation (617% of patients): May require increased fiber intake and hydration Abdominal pain or discomfort (610% of patients): Usually mild to moderate in severity Decreased appetite : Therapeutic effect but may be excessive in some individuals These gastrointestinal symptoms generally diminish over several weeks as the body adjusts to the medication
Injection sites: The stomach, thigh, and upper arm are all approved injection sites for tirzepatide